Join
Live feed
·
INSIDERFilingvia Quantisnow
Synaptogenix Inc. logo

SEC Form 4: Alkon Daniel L. bought $82,600 worth of Common Stock (10,000 units at $8.26), increasing direct ownership by 674% to 11,484 units

ByQuantisnow·Wall Street's wire, on your screen.
SNPX· Synaptogenix Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SNPX (Synaptogenix Inc.) and more on Quantisnow.